Skip to content
buyModerate cluster of 4

Kenneth A. Stauderman bought $1,850 of CALC

Chief Scientific Officer at CalciMedica, Inc.. 1,000 shares at an average of $1.85, traded Jul 1, 2025, filed Jul 2, 2025.

Conviction score
56
Value
$1,850
1,000 shares
Holdings after
1,000
change unknown
From 52-week low
+9%
low $7.15, close $7.80
From 52-week high
-69%
high $24.95, as of Jul 1, 2025

Score components

  • Role
    Officer
    +15
  • Trade size
    $2k at market
    0
  • Relative to holdings
    First purchase: no shares before this trade
    +8
  • Price context
    9% above the 52-week low; 69% below the 52-week high
    +18
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +86.1%, 3m +93.7%, 6m +317.1%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CALCOct 12, 2026 · close 1.21
Since filing Jul 2, 2025: -84.7%SPY +27.1% · excess -111.9%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001415889-25-019190, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jul 1, 2025POpen-market purchase
Common Stockindirect: By Spouse
+1,000$1.85$1,8501,000Jul 2, 2025

Related signals

Other insiders at CalciMedica, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
41Moderate
CALCbuy
CalciMedica, Inc.
Fred A Middleton
director, owner
$200k
248,972 shares
+31%
28Weak
CALCbuy
CalciMedica, Inc.
Eric W Roberts
CHIEF BUSINESS OFFICER
$7,675
2,500 shares
+3%
28Weak
CALCbuy
CalciMedica, Inc.
Eric W Roberts
CHIEF BUSINESS OFFICER
$9,105
3,400 shares
+4%
31Weak
CALCbuy
CalciMedica, Inc.
Eric W Roberts
CHIEF BUSINESS OFFICER
$16k
5,000 shares
+7%
24Weak
CALCbuy
CalciMedica, Inc.
Eric W Roberts
CHIEF BUSINESS OFFICER
$7,378
2,343 shares
+3%
44Moderate
CALCbuy 2
CalciMedica, Inc.
Eric W Roberts
CHIEF BUSINESS OFFICER
$29k
10,000 shares
+16%
39Weak
CALCbuy 2
CalciMedica, Inc.
Eric W Roberts
CHIEF BUSINESS OFFICER
$9,797
3,508 shares
+6%
44Moderate
CALCbuy 2
CalciMedica, Inc.
Sudarshan Hebbar
Chief Medical Officer
$27k
9,563 shares
+18%
39Weak
CALCbuy 2
CalciMedica, Inc.
Eric W Roberts
CHIEF BUSINESS OFFICER
$8,230
3,000 shares
+6%
39Weak
CALCbuy 2
CalciMedica, Inc.
Eric W Roberts
CHIEF BUSINESS OFFICER
$15k
5,076 shares
+10%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kenneth A. Stauderman bought $1,850 of CALC | InsiderTell